Trial intelligence / Profile preview

TIGER: Corticotherapy in IgA Nephropathy

NCT03188887Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Feb 2018
Primary completion
Jan 2024
Countries
1
01

Overview

A Phase 3 trial of corticosteroids in IgA nephropathy (IgAN), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2018; status: completed.

02

Drugs

corticosteroids
03

Conditions

IgA nephropathy (IgAN)

Beyond the preview

Go deeper on NCT03188887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03188887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call